Companies House 15330850 2024-12-31 2024-12-31 2023-12-06 false iso4217:GBP xbrli:pure 15330850 2024-12-31 15330850 2023-12-06 2024-12-31 15330850 curr:PoundSterling 2023-12-06 2024-12-31 15330850 uk-bus:PrivateLimitedCompanyLtd 2023-12-06 2024-12-31 15330850 uk-bus:FRS102 2023-12-06 2024-12-31 15330850 uk-bus:AuditExempt-NoAccountantsReport 2023-12-06 2024-12-31 15330850 uk-bus:FullAccounts 2023-12-06 2024-12-31 15330850 uk-bus:RegisteredOffice 2023-12-06 2024-12-31 15330850 uk-bus:Director1 2023-12-06 2024-12-31 15330850 uk-bus:Director2 2023-12-06 2024-12-31 15330850 uk-bus:Director3 2023-12-06 2024-12-31 15330850 uk-bus:Director4 2023-12-06 2024-12-31 15330850 uk-bus:Director5 2023-12-06 2024-12-31 15330850 uk-bus:Director6 2023-12-06 2024-12-31 15330850 uk-bus:Director7 2023-12-06 2024-12-31 15330850 uk-bus:Director8 2023-12-06 2024-12-31 15330850 uk-bus:Director9 2023-12-06 2024-12-31 15330850 uk-bus:Director10 2023-12-06 2024-12-31 15330850 uk-bus:Director11 2023-12-06 2024-12-31 15330850 uk-bus:Director12 2023-12-06 2024-12-31 15330850 uk-bus:Director13 2023-12-06 2024-12-31 15330850 uk-bus:Director14 2023-12-06 2024-12-31 15330850 uk-bus:Director15 2023-12-06 2024-12-31 15330850 uk-bus:Director16 2023-12-06 2024-12-31 15330850 uk-bus:Director17 2023-12-06 2024-12-31 15330850 uk-bus:Director18 2023-12-06 2024-12-31 15330850 uk-bus:Director19 2023-12-06 2024-12-31 15330850 uk-bus:Director20 2023-12-06 2024-12-31 15330850 uk-bus:Director21 2023-12-06 2024-12-31 15330850 uk-bus:CompanySecretary1 2023-12-06 2024-12-31 15330850 core:AfterOneYear 2024-12-31 15330850 core:WithinOneYear 2024-12-31 15330850 core:WithinOneYear 2023-12-06 2024-12-31 15330850 core:AfterOneYear 2024-12-31 15330850 core:AfterOneYear 2023-12-06 2024-12-31 15330850 core:ShareCapital 2024-12-31 15330850 core:SharePremium 2024-12-31 15330850 core:OtherReservesSubtotal 2024-12-31 15330850 core:RevaluationReserve 2024-12-31 15330850 core:RetainedEarningsAccumulatedLosses 2024-12-31 15330850 1 2023-12-06 2024-12-31 15330850 2 2023-12-06 2024-12-31 15330850 3 2023-12-06 2024-12-31 15330850 core:LandBuildings 2023-12-06 2024-12-31 15330850 core:LandBuildings 2024-12-31 15330850 core:PlantMachinery 2023-12-06 2024-12-31 15330850 core:PlantMachinery 2024-12-31 15330850 core:FurnitureFittingsToolsEquipment 2023-12-06 2024-12-31 15330850 core:FurnitureFittingsToolsEquipment 2024-12-31 15330850 core:OfficeEquipment 2023-12-06 2024-12-31 15330850 core:OfficeEquipment 2024-12-31 15330850 core:Vehicles 2023-12-06 2024-12-31 15330850 core:Vehicles 2024-12-31 15330850 core:NetGoodwill 2023-12-06 2024-12-31 15330850 core:NetGoodwill 2024-12-31 15330850 core:IntangibleAssetsOtherThanGoodwill 2023-12-06 2024-12-31 15330850 core:IntangibleAssetsOtherThanGoodwill 2024-12-31

# GCS MEDICAL LTD

## Company Registration Number:
15330850 (England and Wales)

## Unaudited statutory accounts for the year ended 31 December 2024

## Period of accounts

## Start date: 6 December 2023

## End date: 31 December 2024

# GCS MEDICAL LTD

## Contents of the Financial Statements

for the Period Ended 31 December 2024

Directors report |
Balance sheet |
Additional notes |
Balance sheet notes |

# GCS MEDICAL LTD

Directors' report period ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Principal activities of the company

Sedation Services

Directors

The director shown below has held office during the whole of the period from
6 December 2023 to 31 December 2024

Garry Summers

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
5 December 2025

And signed on behalf of the board by:
Name: Garry Summers
Status: Director

# GCS MEDICAL LTD

## Balance sheet

As at 31 December 2024

| Notes | 13 months to 31 December 2024
--- | --- | ---
|  | £
Current assets
Debtors: | 3 | 2,000 |
Cash at bank and in hand: |  | 6,195 |
Total current assets: |  | 8,195
Creditors: amounts falling due within one year: | 4 | ( 7,578 ) |
Net current assets (liabilities): |  | 617
Total assets less current liabilities: |  | 617
Total net assets (liabilities): |  | 617
Capital and reserves
Called up share capital: |  | 100 |
Profit and loss account: |  | 517 |
Total Shareholders' funds: |  | 617

The notes form part of these financial statements

# GCS MEDICAL LTD

## Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 5 December 2025
and signed on behalf of the board by:

Name: Garry Summers
Status: Director

The notes form part of these financial statements

# GCS MEDICAL LTD

## Notes to the Financial Statements

for the Period Ended 31 December 2024

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Turnover policy

  Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied. It is recognised to the extent that it is probable that the economic benefit will flow to the Company and the turnover can be reliably measured. The following criteria must also be met before turnover is recognised: Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract.

  Other accounting policies

  Judgements and key sources of estimated uncertainty The preparation of the financial statements requires management to make judgements estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances Corporation Tax The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

# GCS MEDICAL LTD

## Notes to the Financial Statements

for the Period Ended 31 December 2024

- ## 2. Employees

  | 13 months to 31 December 2024
  --- | ---
  Average number of employees during the period | 2 |

# GCS MEDICAL LTD

## Notes to the Financial Statements

for the Period Ended 31 December 2024

## 3. Debtors

| 13 months to 31 December 2024
--- | ---
| £
Other debtors | 2,000 |
Total | 2,000

# GCS MEDICAL LTD

## Notes to the Financial Statements

for the Period Ended 31 December 2024

## 4. Creditors: amounts falling due within one year note

| 13 months to 31 December 2024
--- | ---
| £
Taxation and social security | 6,220 |
Accruals and deferred income | 720 |
Other creditors | 638 |
Total | 7,578